VENKATAPURAM REDDY: Open Payments
NPI 1770678302 · HALEYVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 10 payments from 9 companies in 2025. Trend: 2023 $420 · 2024 $313 · 2025 $221
Food & beverage: $176Education: $45
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $45 |
| ABBVIE INC. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| PFIZER INC. | 1 | $20 |
| Corcept Therapeutics | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: FANAPT, LINZESS, ELIQUIS, Korlym, JOURNAVX, BREZTRI, CAPLYTA, UBRELVY.
Industry payments across AL — which companies pay providers there.
